GlassScriptPhysician profile
Sean Chan
NPI 1558008367
$2,120.99
in general payments reported to CMS, 2019-2025
10 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,349 · 2023: $226 · 2024: $385 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elevate Surgical Co | $1,255.90 | 2022-2025 | |
| Osteocentric Technologies, INC. | $236.29 | 2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Orthofix Medical, INC. | $148.47 | 2024 | Accelstim |
| Kci USA, INC. | $125.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $124.15 | 2023 | Enhertu |
| Stryker Corporation | $86.47 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $80.09 | 2025 | Iovera |
| Solventum Corporation | $37.04 | 2025 | Prevena |
| Paragon 28, INC. | $14.99 | 2023 | Gorilla |
| Skeletal Dynamics INC | $12.59 | 2025 | Geminus, Ijs, Align |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.